SCM
ETNB

Soleus Capital Management’s 89bio ETNB Stock Holding History

Soleus Capital Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-346,033
Closed -$5.34M – 87
2023
Q3 		$5.34M Buy
346,033
+119,533
+53% +$2.01M 0.49% 52
2023
Q2 		$4.29M Sell
226,500
-267,500
-54% -$4.7M 0.48% 52
2023
Q1 		$7.52M Buy
494,000
+115,000
+30% +$1.5M 0.78% 37
2022
Q4 		$4.82M Buy
379,000
+49,000
+15% +$441K 0.69% 41
2022
Q3 		$1.91M Buy
+330,000
New +$1.45M 0.26% 58

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Soleus Capital Management's ETNB Position: Q4 2023 in Review

Soleus Capital Management sold out of 89bio (ETNB) in Q4 2023, closing a stake of 346,033 shares — an estimated $5.34M sold.

Soleus Capital Management first reported a position in ETNB in Q3 2022 and held it in 5 quarters. The position peaked at $7.52M in Q1 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Soleus Capital Management reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Soleus Capital Management sold 346,033 89bio shares in Q4 2023, an estimated $5.34M.
  • Soleus Capital Management first reported a position in 89bio in Q3 2022 and held it in 5 quarters.
  • Soleus Capital Management's 89bio position peaked at $7.52M in Q1 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Soleus Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.